skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Non-Nucleoside Reverse Transcriptase Inhibitors

Delavirdine (Rescriptor, DLV)

(Last updated:March 28, 2014; last reviewed:March 28, 2014)

Delavirdine is no longer available in the United States.

Back to Top